Pages that link to "Q40131320"
Jump to navigation
Jump to search
The following pages link to High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer (Q40131320):
Displaying 50 items.
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression (Q24635943) (← links)
- Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology (Q26799114) (← links)
- Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents (Q26830743) (← links)
- CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting (Q26849606) (← links)
- Chemokines and chemokine receptors: update on utility and challenges for the clinician (Q27687402) (← links)
- A multi-targeted approach to suppress tumor-promoting inflammation (Q28393278) (← links)
- Chemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells (Q30412948) (← links)
- Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis (Q30432069) (← links)
- The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers (Q30438926) (← links)
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors (Q30505678) (← links)
- Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation (Q33802647) (← links)
- The emerging role of CXC chemokines and their receptors in cancer (Q34263645) (← links)
- Noninvasive detection of inflammation-associated colon cancer in a mouse model (Q34411737) (← links)
- Combinations of immunotherapy and radiation in cancer therapy. (Q34582640) (← links)
- CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages. (Q34990965) (← links)
- Enhancement of T cell recruitment and infiltration into tumours. (Q35178939) (← links)
- CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro (Q35181573) (← links)
- Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas (Q35433402) (← links)
- Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival (Q35645484) (← links)
- Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer. (Q36475434) (← links)
- CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering (Q36916482) (← links)
- Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. (Q36983211) (← links)
- CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control (Q37079121) (← links)
- Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer (Q37100703) (← links)
- Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer (Q37111136) (← links)
- Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines (Q37115310) (← links)
- Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies (Q37134430) (← links)
- CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein (Q37197326) (← links)
- Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype (Q37407802) (← links)
- International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors (Q37432097) (← links)
- Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy. (Q37537926) (← links)
- Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity. (Q37650715) (← links)
- Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer (Q37689104) (← links)
- Chemokines in cancer related inflammation (Q37816561) (← links)
- Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence (Q38197678) (← links)
- Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment (Q38223355) (← links)
- Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo (Q38292325) (← links)
- Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling (Q38881161) (← links)
- Blockade of the CXCR6 signaling inhibits growth and invasion of hepatocellular carcinoma cells through inhibition of the VEGF expression (Q38921923) (← links)
- Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells (Q38986743) (← links)
- Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients (Q39489655) (← links)
- Expression of CXCR6 on CD8(+) T cells was up-regulated in allograft rejection (Q39758876) (← links)
- The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation (Q39971704) (← links)
- CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells (Q39985978) (← links)
- The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells (Q41819129) (← links)
- Reply to low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer: The question is still open (Q44090824) (← links)
- Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high grade and muscle invasive urothelial carcinomas (Q47093667) (← links)
- Plasma levels of the proangiogenic protein CXCL16 remains elevated for 1 month after minimally invasive colorectal cancer resection. (Q55605662) (← links)
- Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma (Q61813707) (← links)
- Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation (Q64121793) (← links)